Media

NewsMedia

Further data from Tuteva™ clinical validation study presented

June 14, 2022

Performance in blinded multi-centre trial establishes new industry standard in detection of acute kidney transplant rejection and paves way for US commercial launch in 2022

Keep Reading

Commercial Team Appointments

June 9, 2022

Verici Dx plc announces the senior appointments of Grant Harvey and Dr. Windy Tucci as Business Development Director and Medical Science Liaison Director

Keep Reading

Posting of Annual Report & Accounts and Notice of Annual General Meeting

May 25, 2022

Verici Dx plc confirms that the Annual Report and Accounts and the Notice of the 2022 Annual General Meeting have now been published

Keep Reading

Final Results and Post Year-End Update

May 19, 2022

Verici Dx plc announces its audited final results for the period ended 31 December 2021

Keep Reading

Positive results for Tutivia™ from the international clinical validation study

May 12, 2022

Performance in blinded multi-centre trial establishes new industry standard in detection of acute kidney transplant rejection and paves way for commercial launch in United States in 2022

Keep Reading